BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33249944)

  • 1. Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions.
    Lefever E; Vliebergh J; Mathieu C
    Expert Opin Drug Saf; 2021 Feb; 20(2):155-169. PubMed ID: 33249944
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of insulin analogues as compared with human insulin in pregnancy.
    Toledano Y; Hadar E; Hod M
    Expert Opin Drug Saf; 2016 Jul; 15(7):963-73. PubMed ID: 27145344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
    Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
    Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin analogues: new dimension of management of diabetes mellitus.
    Siddiqui NI
    Mymensingh Med J; 2007 Jan; 16(1):117-21. PubMed ID: 17344794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment options for type 1 diabetes: what's new?
    Nally LM; Sherr JL; Van Name MA; Patel AD; Tamborlane WV
    Expert Rev Clin Pharmacol; 2019 May; 12(5):471-479. PubMed ID: 30892094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
    Lajara R; Cengiz E; Tanenberg RJ
    Curr Med Res Opin; 2017 Jun; 33(6):1045-1055. PubMed ID: 28277867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.
    Shafie AA; Ng CH; Tan YP; Chaiyakunapruk N
    Pharmacoeconomics; 2017 Feb; 35(2):141-162. PubMed ID: 27752998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
    Goldman J; Kapitza C; Pettus J; Heise T
    Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Hypoglycemia and Safety Outcomes With Long-Acting Insulins Versus Insulin NPH in Pregestational and Gestational Diabetes.
    Sleeman A; Odom J; Schellinger M
    Ann Pharmacother; 2020 Jul; 54(7):669-675. PubMed ID: 31893932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin therapy-new insulin analogues].
    Ehren M; Klein HH
    Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
    Heinemann L
    J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin degludec. Uncertainty over cardiovascular harms.
    Prescrire Int; 2014 Jun; 23(150):149. PubMed ID: 25121146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of basal insulins.
    Barnett AH
    Diabet Med; 2003 Nov; 20(11):873-85. PubMed ID: 14632712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.